|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
5
|
|
pubmed:dateCreated |
1997-10-16
|
|
pubmed:abstractText |
Age is considered one of the important contraindications to surgery for hepatocellular carcinoma (HCC) in cirrhosis patients. We therefore evaluated the safety and prevalence of side effects in endoarterial therapy (EAT) in subjects aged over 65 years compared with younger treated patients.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
AIM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Sep
|
|
pubmed:issn |
1079-5006
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
52
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
M305-9
|
|
pubmed:dateRevised |
2006-11-15
|
|
pubmed:meshHeading |
pubmed-meshheading:9310085-Adult,
pubmed-meshheading:9310085-Aged,
pubmed-meshheading:9310085-Aged, 80 and over,
pubmed-meshheading:9310085-Carcinoma, Hepatocellular,
pubmed-meshheading:9310085-Chemoembolization, Therapeutic,
pubmed-meshheading:9310085-Contrast Media,
pubmed-meshheading:9310085-Female,
pubmed-meshheading:9310085-Humans,
pubmed-meshheading:9310085-Iodized Oil,
pubmed-meshheading:9310085-Liver Neoplasms,
pubmed-meshheading:9310085-Male,
pubmed-meshheading:9310085-Middle Aged,
pubmed-meshheading:9310085-Prognosis,
pubmed-meshheading:9310085-Survival Rate
|
|
pubmed:year |
1997
|
|
pubmed:articleTitle |
Chemoembolization versus chemotherapy in elderly patients with unresectable hepatocellular carcinoma and contrast uptake as prognostic factor.
|
|
pubmed:affiliation |
G. Fontana Center for the Multidisciplinary Study and Treatment of Alcohol Abuse, University of Bologna, Italy.
|
|
pubmed:publicationType |
Journal Article,
Comparative Study,
Research Support, Non-U.S. Gov't
|
